HAWTHORNE, N.Y. & NEWTOWN, Pa.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company” Pink Sheets: TAROF) and Quinnova Pharmaceuticals, Inc. (“Quinnova”) today announced that Taro’s U.S. subsidiary (“Taro USA”) and Quinnova have entered into an agreement to co-promote “Neosalus” and “Cleanse & Treat” (the “Co-Promote Products”) in the United States.
